Triptan cardiovascular caution — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Do not supply and refer for medical assessment
Triptans are contraindicated or unsuitable in patients with significant ischaemic heart disease because of vasoconstrictive effects. The patient's nitrate therapy and previous myocardial infarction make over-the-counter supply inappropriate. New or severe headache patterns also require careful assessment.
Reference: https://www.pharmacyregulation.org/registration-assessment#stage-8-order-77